KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Non-Current Assets (2016 - 2025)

Gilead Sciences (GILD) has disclosed Other Non-Current Assets for 17 consecutive years, with $4.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 28.55% year-over-year to $4.8 billion, compared with a TTM value of $4.8 billion through Dec 2025, up 28.55%, and an annual FY2025 reading of $4.8 billion, up 28.55% over the prior year.
  • Other Non-Current Assets was $4.8 billion for Q4 2025 at Gilead Sciences, down from $4.9 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.6 billion in Q2 2021 and bottomed at $3.8 billion in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $4.8 billion, with a median of $4.9 billion recorded in 2022.
  • The sharpest move saw Other Non-Current Assets soared 30.81% in 2024, then dropped 25.39% in 2025.
  • Year by year, Other Non-Current Assets stood at $5.0 billion in 2021, then dropped by 3.28% to $4.8 billion in 2022, then fell by 0.17% to $4.8 billion in 2023, then fell by 21.35% to $3.8 billion in 2024, then increased by 28.55% to $4.8 billion in 2025.
  • Business Quant data shows Other Non-Current Assets for GILD at $4.8 billion in Q4 2025, $4.9 billion in Q3 2025, and $4.0 billion in Q2 2025.